Atropine eye drops to prevent nearsightedness in children
Treatments studied
Part of Eyes & vision clinical trials.
This study tests if using atropine eye drops in increasing doses can prevent nearsightedness (myopia) in children who are at risk. It is for children aged 6 to 9 who do not yet need glasses but have early signs of developing myopia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 9 years old.
- Your child's eyes should not need glasses yet (they are not nearsighted), but they are at risk for myopia based on age and eye measurement.
- Your child has not used any myopia control treatments before (like atropine drops, special contacts, or red light therapy).
- Your child has no other eye diseases or serious health problems.
- Both you and your child must agree to join the study by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This study tests if low-dose atropine eye drops can slow down worsening nearsightedness in children. Children in the study receive either the drops or no treatment, and their vision changes are tracked over time.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hear when a new Pre-myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.